172 related articles for article (PubMed ID: 26194144)
1. Can we shorten the overall treatment time in postoperative brachytherapy of endometrial carcinoma? Comparison of two brachytherapy schedules.
Rovirosa A; Ascaso C; Arenas M; Sabater S; Herreros A; Camarasa A; Rios I; Holub K; Pahisa J; Biete A
Radiother Oncol; 2015 Jul; 116(1):143-8. PubMed ID: 26194144
[TBL] [Abstract][Full Text] [Related]
2. Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients.
Ríos I; Rovirosa A; Ascaso C; Valduvieco I; Herreros A; Castilla L; Sabater S; Holub K; Pahisa J; Biete A; Arenas M
Clin Transl Oncol; 2016 Sep; 18(9):925-30. PubMed ID: 26661111
[TBL] [Abstract][Full Text] [Related]
3. A new short daily brachytherapy schedule in postoperative endometrial carcinoma. Preliminary results.
Rovirosa Á; Ascaso C; Herreros A; Sánchez J; Holub K; Camarasa A; Sabater S; Oses G; García-Miguel J; Rivera Y; Arenas M
Brachytherapy; 2017; 16(1):147-152. PubMed ID: 28029590
[TBL] [Abstract][Full Text] [Related]
4. Three or four fractions per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. The long-term results on vaginal relapses and toxicity.
Valduvieco I; Rovirosa Á; Herreros A; Romera I; Ríos I; Ascaso C; Sánchez-Reyes A; Arenas M; Pahisa J; Biete A
Clin Transl Oncol; 2013 Aug; 15(8):602-7. PubMed ID: 23263910
[TBL] [Abstract][Full Text] [Related]
5. Comparative results of three short brachytherapy schedules as exclusive treatment in postoperative endometrial carcinoma.
Rovirosa Á; Herreros A; Camacho C; Ascaso C; Sánchez J; Cortés S; Sabater S; Solà J; Torné A; Arenas M
Brachytherapy; 2017; 16(6):1169-1174. PubMed ID: 28801116
[TBL] [Abstract][Full Text] [Related]
6. Three or four fractions of 4-5 Gy per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma.
Rovirosa A; Ascaso C; Sánchez-Reyes A; Herreros A; Abellana R; Pahisa J; Lejarcegui JA; Biete A
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):418-23. PubMed ID: 20800388
[TBL] [Abstract][Full Text] [Related]
7. Are 7.5 Gy×2 fractions more efficient than 6 Gy×3 in exclusive postoperative endometrial cancer brachytherapy? A clinical and dosimetrical analysis.
Noorian F; Abellana R; Zhang Y; Herreros A; Baltrons C; Lancellota V; Tagliaferri L; Sabater S; Torne A; Rovirosa A
Radiother Oncol; 2023 Dec; 189():109909. PubMed ID: 37699447
[TBL] [Abstract][Full Text] [Related]
8. Daily schedule for high-dose-rate brachytherapy in postoperative treatment of endometrial carcinoma.
Rovirosa A; Valduvieco I; Ascaso C; Herreros A; Bautista C; Romera I; Arenas M; Pahisa J; Biete A
Clin Transl Oncol; 2013 Feb; 15(2):111-6. PubMed ID: 22855177
[TBL] [Abstract][Full Text] [Related]
9. Is one brachytherapy fraction of 7 Gy similar to more fractions after external beam irradiation in postoperative endometrial carcinoma?
Zhang Y; Ascaso C; Herreros A; Sánchez J; Del Pino M; Torné A; Li Y; Sabater S; Arenas M; Biete A; Rovirosa Á
Clin Transl Oncol; 2020 Aug; 22(8):1295-1302. PubMed ID: 31865604
[TBL] [Abstract][Full Text] [Related]
10. Economic impact of decreasing the fraction number in vaginal cuff brachytherapy: A direct cost analysis.
Zhang Y; Rovirosa A; Ascaso C; Herreros A; Torne A; Li Y; Biete A; Sánchez J
Brachytherapy; 2020; 19(1):60-65. PubMed ID: 31587986
[TBL] [Abstract][Full Text] [Related]
11. Preliminary results of a vaginal constraint for reducing G2 late vaginal complications after postoperative brachytherapy in endometrial cancer: a prospective analysis.
Zhang Y; Gomez G; Ascaso C; Herreros A; Fornes B; Mases J; Rochera J; Tagliaferri L; Sabater S; Torne A; Biete A; Rovirosa Á
Clin Transl Oncol; 2022 May; 24(5):875-881. PubMed ID: 34854030
[TBL] [Abstract][Full Text] [Related]
12. A new method of anatomically conformal vaginal cuff HDR brachytherapy.
Miller DA; Richardson S; Grigsby PW
Gynecol Oncol; 2010 Mar; 116(3):413-8. PubMed ID: 19892389
[TBL] [Abstract][Full Text] [Related]
13. An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early-stage endometrial cancer.
Barney BM; MacDonald OK; Lee CM; Rankin J; Gaffney DK
Brachytherapy; 2007; 6(3):201-6. PubMed ID: 17681241
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the biological effective dose of 50-kV electronic brachytherapy with (192)Ir high-dose-rate brachytherapy for vaginal cuff irradiation.
Rava P; Dvorak T; Markelewicz RJ; Hiatt JR; Sternick ES; MacAusland SG; Huber K; Wazer DE; Hepel JT
Brachytherapy; 2012; 11(5):402-7. PubMed ID: 21996539
[TBL] [Abstract][Full Text] [Related]
15. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
Small W; Erickson B; Kwakwa F
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
[TBL] [Abstract][Full Text] [Related]
16. Are endometrial cancer radiotherapy results age related?
Rovirosa Á; Cortés KS; Ascaso C; Glickman A; Valdés S; Herreros A; Camacho C; Sánchez J; Zhang Y; Li Y; Sabater S; Arenas M; Torne A
Clin Transl Oncol; 2018 Nov; 20(11):1416-1421. PubMed ID: 29651671
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant brachytherapy for endometrial cancer: advantages of the vaginal mold technique.
El Khoury C; Dumas I; Tailleur A; Morice P; Haie-Meder C
Brachytherapy; 2015; 14(1):51-5. PubMed ID: 25183208
[TBL] [Abstract][Full Text] [Related]
18. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
[TBL] [Abstract][Full Text] [Related]
19. Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma.
Park HS; Ratner ES; Lucarelli L; Polizzi S; Higgins SA; Damast S
Brachytherapy; 2015; 14(4):464-70. PubMed ID: 25887343
[TBL] [Abstract][Full Text] [Related]
20. EQD2 Analyses of Vaginal Complications in Exclusive Brachytherapy for Postoperative Endometrial Carcinoma.
Zhang Y; Fornes B; Gómez G; Bentoldrà I; Carmona C; Herreros A; Sabater S; Nicolás I; Li Y; Sánchez J; Biete A; Torné A; Ascaso C; Rovirosa Á
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33092163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
